Mechanisms of the blockade of glutamate channel receptors: Significance for structural and physiological investigations

Neuroscience and Behavioral Physiology

Volumn 37, Issue 3, 2007, Pages 277-284

  Magazanik, L G ^a   Tikhonov, D B ^a   Tikhonova, T B ^a   Lukomskaya, N Ya ^a  

^a SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

Author keywords

Blockade; Channels; Glutamate receptors; Rats

Indexed keywords

1 ADAMANTYLMETHYLAMMONIO 5 AMMONIOPENTANE DIBROMIDE; AMPA RECEPTOR; ARECOLINE; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR ANTAGONIST; IEM 1921; IONOTROPIC RECEPTOR; MEMANTINE; N (5 AMINOPENTYL) 1 PHENYLCYCLOHEXYLAMINEDIBROMIDE; N (5 AMMONIOPENTYL) 1 PHENYLCYCLOHEXYLAMMONIUM DIBROMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CHANNEL GATING; CHOLINERGIC NERVE CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BINDING SITE; DRUG DOSAGE FORM COMPARISON; DRUG DOSE INCREASE; DRUG MECHANISM; DRUG MEGADOSE; DRUG RECEPTOR BINDING; EXPERIMENTAL THERAPY; HIPPOCAMPUS; HYPERPOLARIZATION; MOUSE; NERVE CELL MEMBRANE POTENTIAL; NONHUMAN; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PYRAMIDAL NERVE CELL; RAT; RECEPTOR BLOCKING; TREMOR; WHOLE CELL;

ANIMALS; ANIMALS, NEWBORN; ARECOLINE; DIAMINES; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; HIPPOCAMPUS; ION CHANNEL GATING; KAINIC ACID; MEMBRANE POTENTIALS; MICE; N-METHYLASPARTATE; NEURONS; PATCH-CLAMP TECHNIQUES; QUATERNARY AMMONIUM COMPOUNDS; RATS; RATS, WISTAR; RECEPTORS, GLUTAMATE; TREMOR;

EID: 33947393557     PISSN: 00970549     EISSN: 1573899X     Source Type: Journal    
DOI: 10.1007/s11055-007-0012-9     Document Type: Article

References (29)

1. N. Ya. Lukomskaya, V. V. Lavrent'eva, L. A. Starshinova, E. P. Zhabko, L. V. Gorbunova, T. B. Tikhonova, V. E. Gmiro, and L. G. Magazanik, "Effects of blockers of ionotropic glutamate receptor channels on the development of pentylenetetrazole kindling in mice," Ros. Fiziol. Zh. im. I. M. Sechenova, 91, No. 11, 1241-1250 (2005).
2. N. Ya. Lukomskaya, N. I. Rukoyatkina, L. V. Gorbunova, V. E. Gmiro, K. V. Bol'shakov, and L. G. Magazanik, "Comparison of the anticonvulsive activity of organic mono-and dications and their ability to inhibit NMDA and AMPA glutamate receptors," Ros. Fiziol. Zh. im. I. M. Sechenova, 88, No. 9, 1161-1171 (2002).
3. N. Ya. Lukomskaya, N. I. Rukoyatkina, L. V. Gorbunova, V. E. Gmiro, and L. G. Magazanik, "Studies of the roles of NMDA and AMPA glutamate receptors in the mechanism of convulsive syndrome induced in mice by administration of corasol," Ros. Fiziol. Zh. im. I. M. Sechenova, 89, No. 3, 292-301 (2003).
4. L. G. Magazanik, "Ion channel blockade as an approach to studying AMPA receptor subtypes," Ros. Fiziol. Zh. im. I. M. Sechenova, 84, No. 10, 994-1005 (1998).
5. L. G. Magazanik, K. V. Bol'shakova, S. L. Buldakova, V. E. Gmiro, N. A. Dorofeeva, N. Ya. Lukomskaya, N. N. Potap'eva, M. V. Samoilova, D. B. Tikhonov, I. M. Fedorova, and E. V. Frolova, "Structural characteristics of ionotropic glutamate receptors identified by channel blockade," Ros. Fiziol. Zh. im. I. M. Sechenova, 86, No. 9, 1138-1151 (2000).
6. N. I. Rukoyatkina, L. V. Gorbunova, V. E. Gmiro, and N. Ya. Lukomskaya, "The ability of glutamate receptor antagonists to decrease the severity of experimental catalepsy in mice," Ros. Fiziol. Zh. im. I. M. Sechenova, 86, No. 6, 626-634 (2000).
7. N. I. Rukoyatkina, L. V. Gorbunova, V. E. Gmiro, and N. Ya. Lukomskaya, "The ability of new non-competitive glutamate receptor blockers to decrease motor impairments in animals," Ros. Fiziol. Zh. im. I. M. Sechenova, 87, No. 9, 1260-1267 (2001).
8. T. B. Tikhonova, D. B. Tikhonov, and L. G. Magazanik, "Characteristics of the blockade of NMDA and AMPA glutamate receptor ion channels by dicationic derivatives of phenylcyclohexyl," Biol. Membrany, 22, No. 4, 290-299 (2005).
9. K. V. Bolshakov, D. B. Tikhonov, V. E. Gmiro, and L. G. Magazanik, "Different arrangement of hydrophobic and nucleophilic components of channel binding sites in NMDA and AMPA receptor is revealed by channel blockade," Neurosci. Lett., 291, No. 2, 101-104 (2000).
10. K. V. Bolshakov, G. E. Gmiro, D. B. Tikhonov, and L. G. Magazanik, "Determinants of trapping block of N-methyl-D-aspartate receptor channels," J. Neurochem., 87, No. 1, 56-65 (2003).
11. K. V. Bolshakov, K. H. Kim, N. N. Potapjeva, V. E. Gmiro, D. B. Tikhonov, P. N. R. Usherwood, I. R. Mellor, and L. G. Magazanik, "Design of antagonists for NMDA and AMPA receptors," Neuropharmacol., 49, 144-155 (2005).
12. S. L. Buldakova, V. S. Vorobjev, I. N. Sharonova, M. V. Samoilova, and L. G. Magazanik, "Characterization of AMPA receptor populations in rat brain cells by the use of subunit-specific open channel blocking drug, IEM-1460," Brain Res., 94, No. 1, 261-268 (1999).
13. N. Burnashev, A. Villarroel, and B. Sakmann, "Dimensions and ion selectivity of recombinant AMPA and kainate receptor channels and their dependence on Q/R site residues," J. Physiol. (London), 496, 165-173 (1996).
14. R. Dingledine, K. Borges, D. Bowie, and S. F. Traynelis, "The glutamate receptor ion channels," Pharmacol. Rev., 51, 7-61 (1999).
15. S. A. Lipton, "Prospects for clinically tolerated NMDA antagonists: open channel blockers and alternative redox states of nitric oxide," Trends Neurosci., 16, 527-532 (1993).
16. L. G. Magazanik, S. L. Buldakova, M. V. Samoilova, V. E. Gmiro, I. R. Mellor, and P. N. R. Usherwood, "Block of open channels of recombinant AMPA receptors and native AMPA/kainate receptors by adamantane derivatives," J. Physiol. (London), 505, No. 3, 655-663 (1997).
17. L. Nowak, P. Bregestovski, P. Ascher, A. Herbet, and A. Prochiantz, "Magnesium gates glutamate-activated channels in mouse central neurones," Nature, 307, 462-465 (1984).
18. C. G. Parsons, W. Danysz, and G. Quack, "Glutamate in CNS disorders as a target for drug development: An update," Drug New Perspect., 11, 523-569 (1998).
19. C. G. Parsons, W. Danysz, and G. Quack, "Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist - a review of preclinical data," Neuropharmacol., 38, 735-767 (1999).
20. M. Rogawski, "Therapeutic potential of excitatory amino acid antagonists: Channel blockers and 2,3-benzodiazepines," Trends Pharmacol. Sci., 14, 325-331 (1993).
21. M. Rogawski, "Low affinity channel blocking (uncompetitive) NMDA receptor antagonists as therapeutic agents-toward an understanding of their favorable tolerability," Amino Acids, 19, 133-149 (2000).
22. M. V. Samoilova, S. L. Buldakova, V. S. Vorobjev, I. N. Sharonova, and L. G. Magazanik, "Open channel blocking drug, IEM-1460, reveals functionally distinct α-amino-3-hydroxy-5 methyl-4-isoxazolepropionate receptors in rat brain neurons," Neurosci., 94, No. 1, 261-268 (1999).
23. D. B. Tikhonov and L. G. Magazanik, "Voltage dependence of open channel blockade: Onset and offset rates," J. Membr. Biol., 161, No. 1, 1-8 (1998).
24. D. B. Tikhonov, M. V. Samoilova, S. L. Buldakova, V. E. Gmiro, and L. G. Magazanik, "Voltage-dependent block of native AMPA receptor channels by dicationic compounds," Britain. J. Pharmacol., 129, No. 2, 265-274 (2000).
25. A. Villarroel, N. Burnashev, and B. Sakmann, "Dimensions of the narrow portion of a recombinant NMDA receptor channel," Biophys. J., 68, 866-875 (1996).
26. V. S. Vorobjev, "Vibrodissociation of sliced mammalian nervous tissue," J. Neurosci. Meth., 38, 145-150 (1991).
27. 2+ interacts with structural determinants of the narrow constriction contributed by the NR1-subunit in the NMDA receptor channel," J. Physiol. (London), 506, 33-52 (1998).
28. A. M. Woodhull, "Ionic blockage of sodium channels in nerve," J. Gen. Physiol., 61, 687-708 (1973).
29. E. V. Zeimal and Z. Votava, "Antagonism against the arecoline tremors of oxyphenonium and its tertiary analogue after intravenous and intracerebral administration in mice," Experientia, 15, No. 17, 471-472 (1961).